Follow the science?

Follow the science?

The U.S. Food and Drug Administration (FDA) announced late Thursday afternoon that it has limited the authorized use of the Johnson & Johnson vaccine to adults who cannot receive other coronavirus vaccines.
The FDA said in a statement, “After conducting an updated analysis, evaluation and investigation of reported cases, the FDA has determined that the risk of thrombosis with thrombocytopenia syndrome (TTS), a syndrome of rare and potentially life-threatening blood clots in combination with low levels of blood platelets with onset of symptoms approximately one to two weeks following administration of the Janssen COVID-19 Vaccine, warrants limiting the authorized use of the vaccine.”
SOURCE: http://dlvr.it/SPr5zl
The FDA said that the potential benefits for the vaccine outweighed its potential risks “for individuals 18 years of age and older for whom other authorized or approved COVID-19 vaccines are not accessible or clinically appropriate, and for individuals 18 years of age and older who elect to receive the Janssen COVID-19 Vaccine because they would otherwise not receive a COVID-19 vaccine.”